Jump to main content
Jump to site search

Issue 12, 2014
Previous Article Next Article

Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae

Author affiliations

Abstract

Investigating the mechanisms of action (MOAs) of bioactive compounds and the deconvolution of their cellular targets is an important and challenging undertaking. Drug resistance in model organisms such as S. cerevisiae has long been a means for discovering drug targets and MOAs. Strains are selected for resistance to a drug of interest, and the resistance mutations can often be mapped to the drug's molecular target using classical genetic techniques. Here we demonstrate the use of next generation sequencing (NGS) to identify mutations that confer resistance to two well-characterized drugs, benomyl and rapamycin. Applying NGS to pools of drug-resistant mutants, we develop a simple system for ranking single nucleotide polymorphisms (SNPs) based on their prevalence in the pool, and for ranking genes based on the number of SNPs that they contain. We clearly identified the known targets of benomyl (TUB2) and rapamycin (FPR1) as the highest-ranking genes under this system. The highest-ranking SNPs corresponded to specific amino acid changes that are known to confer resistance to these drugs. We also found that by screening in a pdr1Δ null background strain that lacks a transcription factor regulating the expression of drug efflux pumps, and by pre-screening mutants in a panel of unrelated anti-fungal agents, we were able to mitigate against the selection of multi-drug resistance (MDR) mutants. We call our approach “Mutagenesis to Uncover Targets by deep Sequencing”, or “MUTseq”, and show through this proof-of-concept study its potential utility in characterizing MOAs and targets of novel compounds.

Graphical abstract: Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae

Back to tab navigation

Supplementary files

Article information


Submitted
10 Mar 2014
Accepted
19 Sep 2014
First published
19 Sep 2014

Mol. BioSyst., 2014,10, 3179-3187
Article type
Paper
Author version available

Confirmation of the cellular targets of benomyl and rapamycin using next-generation sequencing of resistant mutants in S. cerevisiae

D. A. Wride, N. Pourmand, W. M. Bray, J. J. Kosarchuk, S. C. Nisam, T. K. Quan, R. F. Berkeley, S. Katzman, G. A. Hartzog, C. E. Dobkin and R. Scott Lokey, Mol. BioSyst., 2014, 10, 3179
DOI: 10.1039/C4MB00146J

Search articles by author

Spotlight

Advertisements